NASDAQ · Biotechnology

CRDF (CRDF) Stock

$0.81 -2.98% NASDAQ: CRDF Healthcare

Valuation

MetricValue
Price$0.81
Market Cap$53.22M
P/E Ratio-2.58
P/B Ratio2.70
P/S Ratio231.81
EPS (TTM)$0.00
52-Week High$4.56
52-Week Low$0.81
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-102.22%
ROA-74.19%
ROCE-106.52%
Gross Margin-4900.00%
Operating Margin-4900.00%
Net Margin-85.27%
Debt/Equity0.02
Current Ratio3.75

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$1.0M$1.0M
Operating Profit$-29.0M$-40.0M$-45.0M$-49.0M$-49.0M
Net Profit$-28.0M$-39.0M$-41.0M$-45.0M$-46.0M
EPS$-0.73$-0.89$-0.93$-0.95$-0.69
Op Margin-8037.6%-10337.3%-9305.7%-7123.1%-8256.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$150.0M$116.0M$82.0M$97.0M$62.0M
Total Liabilities$9.0M$10.0M$12.0M$14.0M$16.0M
Cash$12.0M$16.0M$22.0M$51.0M$17.0M
Borrowings$3.0M$3.0M$2.0M$2.0M$1.0M

Latest News

Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital InvestorsHub · Jul 15, 2026 Cardiff Oncology to Raise $10 Million in Share, Warrant Sale MT Newswires · Jul 15, 2026 Cardiff Oncology Announces $10 Million Registered Direct Offering GlobeNewswire · Jul 15, 2026 Is Cardiff Oncology, Inc. (CRDF) Stock Undervalued Amid Legal Uncertainty and Future Cancer Drug Potential? Insider Monkey · Jun 30, 2026 CRDF: Phase II Update; Survival Advantage Extended Zacks Small Cap Research · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-23.0M$-34.0M$-31.0M$-38.0M$-38.0M
Investing Cash Flow$-132.0M$37.0M$36.0M$14.0M$1.0M
Financing Cash Flow$1.0M$0$0$0$0
Net Cash Flow$-119.0M$4.0M$5.0M$30.0M$-34.0M
Free Cash Flow$-23.0M$-35.0M$-31.0M$-38.0M$-38.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-30.78%
Quick Ratio3.27
Interest Coverage—
Return 1Y-80.01%
Return 3Y-38.20%
Return 5Y-84.82%

Ownership

Insiders Held5.91%
Institutions Held32.87%
Institutions Float Held34.94%
Institutional HolderSharesReport Date
Blackrock Inc.3,981,3872026-03-31
Vanguard Capital Management LLC2,855,9662026-03-31
Laurion Capital Management, LP2,646,7382026-03-31
Pfizer Inc2,411,5752026-03-31
Acorn Capital Advisors, LLC 1,762,0842026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APLTApplied Therapeutics, Inc. $0.10 +0.00% -0.24 $14.86M 0.00%
CRBP $9.11 +0.33% -1.95 $168.79M 0.00%
ELTXElicio Therapeutics, Inc. $3.01 +0.17% -1.27 $57.29M 0.00%
FBRX $76.57 +0.08% -4.26 $1.57B 0.00%
IPHAInnate Pharma S.A. $1.79 +0.14% -2.89 $168.32M 0.00%

About CRDF

CRDF is led by CEO Mani Mohindru, employs 32 people, headquartered in US, publicly traded since 2004.

CRDF stock trades at $0.81 with a market capitalization of $53.22M. The stock is valued at a price-to-earnings (P/E) ratio of -2.58, price-to-book of 2.70, price-to-sales of 231.81. Over the past 52 weeks the stock has ranged between $0.81 and $4.56, and currently trades 82.2% below its 52-week high.

On profitability, CRDF generates a return on equity (ROE) of -102.22%, return on capital employed of -106.52%, an operating margin of -4900.00%, a net profit margin of -85.27%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides